Lexaria Bioscience Corp. Quarterly report pursuant to Section 13 or 15(d)

Stock Options (Tables)

3 Months Ended

Nov. 30, 2020

Options

Weighted Average Exercise Price $

Weighted Average Remaining Contractual Term (Years)

Aggregate Intrinsic Value $

Balance August 31, 2019

166,767

21.30

Cancelled/expired

(149,437

)

29.51

Exercised

(7,333

)

4.09

Granted

161,600

11.66

Balance August 31, 2020

171,596

11.17

Cancelled

(1,333

)

12.90

Balance November 30, 2020 (Outstanding)

170,263

11.16

4.05

30,000

Balance November 30, 2020 (Exercisable)

146,231

10.51

4.05

30,000